Publisher
Springer Berlin Heidelberg
Reference69 articles.
1. Adams, J, Palombella VJ, Sausville EA, Johnson J, Destree A, Lazarus DD, Maas J, Pien CS, Prakash S and Elliott P (1999) Proteasome inhibitors: a novel class of potent and effective antitumor agents. Cancer Res, 59, 2615 – 2622
2. Adams, J and Stein R (1996) Novel inhibitors of the proteasome and their therapeutic use in inflammation. Ann Rep Med Chem, 31, 279 – 288
3. Beg, AA and Baltimore D (1996) An essential role for NF-KB in preventing TNF-a-induced cell death. Science, 274, 782 – 784
4. Boffa, LC, Vidali G, Mann RS and Allfrey VG (1978) Suppression of histone deacetylation in vivoand in vitroby sodium butyrate. J Biol Chem, 253 (10), 3364 – 6
5. Brusilow, SW, Danney M, Waber LJ, Batshaw M, Burton B, Levitsky L, Roth K, McKeethren C and Ward J (1984) Treatment of episodic hyperammonemia in children with inborn errors of urea synthesis. N Engl J Med, 310 (25), 1630 – 4